Drug Shortage Report for DIPYRIDAMOLE INJECTION, USP
Report ID | 88601 |
Drug Identification Number | 02244475 |
Brand name | DIPYRIDAMOLE INJECTION, USP |
Common or Proper name | Dipyridamole |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | DIPYRIDAMOLE |
Strength(s) | 5MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS |
Packaging size | 10mL Vial |
ATC code | B01AC |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-08-15 |
Actual start date | |
Estimated end date | 2019-10-15 |
Actual end date | 2019-10-01 |
Shortage status | Resolved |
Updated date | 2019-10-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-07-05 | English | Compare |
v2 | 2019-07-05 | French | Compare |
v3 | 2019-08-02 | English | Compare |
v4 | 2019-08-02 | French | Compare |
v5 | 2019-08-16 | English | Compare |
v6 | 2019-10-01 | English | Compare |
v7 | 2019-10-01 | French | Compare |
v8 | 2019-10-02 | English | Compare |
Showing 1 to 8 of 8